The business strategies of companies involved in chiral drug development were cast into doubt in October after Eli Lilly (Indianapolis, IL) decided not to pursue the development of R-fluoxetine ...
These topics span a timeframe of approximately four 50-minute class periods. Students should be able to represent and classify stereoisomeric relationships and evaluate the implications of ...
Nearly 56% of all modern drugs and medicine are chiral in nature, and about 90% of those are a mixture containing equal amounts of two enantiomers of a chiral compound. Researchers often face the ...